Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 11/20 | 0.49 |
| ▸ | CTSK | P43235 | 10/20 | 0.49 |
| ▸ | CTSL | P07711 | 2/20 | 0.46 |
| ▸ | CTSB | P07858 | 2/20 | 0.46 |
| ▸ | PPARA | Q07869 | 5/20 | 0.43 |
| ▸ | PPARG | P37231 | 4/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | ACE | P12821 | 1/20 | 0.42 |
| ▸ | PPARD | Q03181 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23273778 | 1.00 | CTSS (0.49) | CTSSCTSKCTSLCTSBPPARA | |
| SCHEMBL23036809 | 1.00 | CTSS (0.49) | CTSSCTSKCTSLCTSBPPARA | |
| SCHEMBL28462855 | 0.91 | CTSK (0.51) | CTSSCTSKCTSLCTSBPPARA | |
| SCHEMBL28462823 | 0.91 | CTSK (0.51) | CTSSCTSKCTSLCTSBPPARA | |
| SCHEMBL4656416 | 0.91 | CTSK (0.51) | CTSSCTSKCTSLCTSBPPARA | |
| SCHEMBL21004186 | 0.86 | CTSK (0.45) | CTSSCTSKCTSLCTSB | |
| SCHEMBL25166303 | 0.86 | CTSK (0.45) | CTSSCTSKCTSLCTSB | |
| SCHEMBL9181378 | 0.86 | CTSS (0.50) | CTSSCTSKCTSLCTSBPPARA | |
| SCHEMBL9181382 | 0.86 | CTSS (0.50) | CTSSCTSKCTSLCTSBPPARA | |
| SCHEMBL14940839 | 0.86 | CTSS (0.50) | CTSSCTSKCTSLCTSBPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111777521-A | Synthesis method of multi-configuration long-chain phenyl amino acid compound | 苏州爱玛特生物科技有限公司 | 2020-10-16 | — | — | CN | disclosed |
| US-10246486-B2 | Macrocyclic inhibitors of flaviviridae viruses | GILEAD SCIENCES, INC. (US) | 2019-04-02 | — | — | US | disclosed |
| US-20170190737-A1 | MACROCYCLIC INHIBITORS OF FLAVIVIRIDAE VIRUSES | CYPRALIS LIMITED (GB) | 2017-07-06 | — | — | US | disclosed |
| US-6018020-A | VIRICIDES WHICH ARE PROTEASE INHIBITORS AGAINST HEPATITIS C AND HEPATITIS G | HOFFMAN-LA ROCHE INC. (US) | 2000-01-25 | — | — | US | disclosed |
| US-5866684-A | Peptidyl inhibitors of viral proteases | HOFFMANN-LA ROCHE INC. (US) | 1999-02-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170190737-A1 | MACROCYCLIC INHIBITORS OF FLAVIVIRIDAE VIRUSES | HAVCR2, ZC3HAV1, HCCS | CTSS 1084/4885CTSK 1762/4885CTSL 862/4885 |
| US-10246486-B2 | Macrocyclic inhibitors of flaviviridae viruses | HAVCR2, ZC3HAV1, HCCS | CTSS 1084/4885CTSK 1762/4885CTSL 862/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.